These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36627817)

  • 1. Pervasive Selection for Clinically Relevant Resistance and Media Adaptive Mutations at Very Low Antibiotic Concentrations.
    Pereira C; Warsi OM; Andersson DI
    Mol Biol Evol; 2023 Jan; 40(1):. PubMed ID: 36627817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance begets more resistance: chromosomal resistance mutations mitigate fitness costs conferred by multi-resistant clinical plasmids.
    Nair RR; Andersson DI; Warsi OM
    Microbiol Spectr; 2024 May; 12(5):e0420623. PubMed ID: 38534122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
    Sandegren L; Lindqvist A; Kahlmeter G; Andersson DI
    J Antimicrob Chemother; 2008 Sep; 62(3):495-503. PubMed ID: 18544599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Ciprofloxacin Concentrations Select Multidrug-Resistant Mutants Overproducing Efflux Pumps in Clinical Isolates of Pseudomonas aeruginosa.
    Sanz-García F; Hernando-Amado S; López-Causapé C; Oliver A; Martínez JL
    Microbiol Spectr; 2022 Oct; 10(5):e0072322. PubMed ID: 36000896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic Minimal Selective Concentrations and Fitness Costs during Biofilm and Planktonic Growth.
    Hjort K; Fermér E; Tang PC; Andersson DI
    mBio; 2022 Jun; 13(3):e0144722. PubMed ID: 35695458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of Escherichia coli hypermutators to selection pressure with antimicrobial agents from different classes.
    Miller K; O'Neill AJ; Chopra I
    J Antimicrob Chemother; 2002 Jun; 49(6):925-34. PubMed ID: 12039884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study.
    Pan AJ; Mei Q; Ye Y; Li HR; Liu B; Li JB
    J Antibiot (Tokyo); 2017 Feb; 70(2):166-173. PubMed ID: 27756910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUsceptibility and Resistance to Fosfomycin and other antimicrobial agents among pathogens causing lower urinary tract infections: findings of the SURF study.
    Tutone M; Bjerklund Johansen TE; Cai T; Mushtaq S; Livermore DM
    Int J Antimicrob Agents; 2022 May; 59(5):106574. PubMed ID: 35307561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.
    Zykov IN; Sundsfjord A; Småbrekke L; Samuelsen Ø
    Infect Dis (Lond); 2016 Feb; 48(2):99-107. PubMed ID: 26414659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fitness of Beta-Lactamase Mutants Depends Nonlinearly on Resistance Level at Sublethal Antibiotic Concentrations.
    Farr AD; Pesce D; Das SG; Zwart MP; de Visser JAGM
    mBio; 2023 Jun; 14(3):e0009823. PubMed ID: 37129484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coli.
    Huseby DL; Pietsch F; Brandis G; Garoff L; Tegehall A; Hughes D
    Mol Biol Evol; 2017 May; 34(5):1029-1039. PubMed ID: 28087782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.
    Ellington MJ; Livermore DM; Pitt TL; Hall LM; Woodford N
    J Antimicrob Chemother; 2006 Oct; 58(4):848-52. PubMed ID: 16891630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of Antibiotic Resistance without Antibiotic Exposure.
    Knöppel A; Näsvall J; Andersson DI
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28893783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli.
    Vervoort J; Xavier BB; Stewardson A; Coenen S; Godycki-Cwirko M; Adriaenssens N; Kowalczyk A; Lammens C; Harbarth S; Goossens H; Malhotra-Kumar S
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7225-33. PubMed ID: 25246406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictable properties of fitness landscapes induced by adaptational tradeoffs.
    Das SG; Direito SO; Waclaw B; Allen RJ; Krug J
    Elife; 2020 May; 9():. PubMed ID: 32423531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unravelling mechanisms of nitrofurantoin resistance and epidemiological characteristics among Escherichia coli clinical isolates.
    Zhang X; Zhang Y; Wang F; Wang C; Chen L; Liu H; Lu H; Wen H; Zhou T
    Int J Antimicrob Agents; 2018 Aug; 52(2):226-232. PubMed ID: 29753133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Daptomycin Tolerance and Resistance Mutations in Methicillin-Resistant Staphylococcus aureus from Adaptive Laboratory Evolution.
    Sulaiman JE; Lam H
    mSphere; 2021 Oct; 6(5):e0069221. PubMed ID: 34585959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-Acquired Uropathogenic
    Carmona-Cartaya Y; Hidalgo-Benito M; Borges-Mateus LM; Pereda-Novales N; González-Molina MK; Quiñones-Pérez D
    MEDICC Rev; 2022 May; 24(2):20-25. PubMed ID: 35648059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a previously selected antibiotic resistance on mutations acquired during development of a second resistance in Escherichia coli.
    Hoeksema M; Jonker MJ; Brul S; Ter Kuile BH
    BMC Genomics; 2019 Apr; 20(1):284. PubMed ID: 30975082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Intrinsic Antibiotic Susceptibility during a Long-Term Evolution Experiment with Escherichia coli.
    Lamrabet O; Martin M; Lenski RE; Schneider D
    mBio; 2019 Mar; 10(2):. PubMed ID: 30837336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.